Catyalyst Pharma (CPRX) Tops Q3 EPS by 1c

Catyalyst Pharma (NASDAQ: CPRX) reported Q3 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c